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Abstract 
Nanoparticle holds significant promise as the next generation of drug carrier that 
can realize targeted therapy with minimal toxicity. To improve the delivery efficiency 
of nanoparticles, it is important to study their transport and deposition in blood flow. 
Many factors, like particle size, vessel geometry and blood flow rate, have significant 
influence on the particle transport, thus on the deposition fraction and distribution. 
In this thesis, computational fluid dynamics (CFD) simulations of blood flow and 
drug particle deposition were conducted in four models representing the human lung 
vasculature: artificial artery geometry, artificial vein geometry, original geometry and 
over-smoothed original geometry. Flow conditions used included both steady-state inlet 
flow and pulsatile inlet flow. Parabolic flow pattern and lumped mathematic model 
were used for inlet and outlet boundary conditions respectively. Blood flow was treated 
as laminar and Newtonian. Particle trajectories were calculated in each of these models 
by solving the integrated force balance on the particle, and adding a stochastic 
Brownian term at each step. A receptor-ligand model was integrated to simulate the 
particle binding probability. The results indicate the following: (i) Pulsatile flow can 
accelerate the particle binding activity and improve the particle deposition fraction on 
bifurcation areas; (ii) Unlike drug delivery in lung respiratory system, particle diffusion 
is very weak in blood flow, no clear relationship between the particle size and 
deposition area was found in our four-generation lung vascular model; and (iii) Surface 
imperfections have the dominant effect on particle deposition fraction over a wide range 
of particle sizes. Ideal artificial geometry is not sufficient to predict drug deposition, 
and an accurate image based geometry is required. 
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Chapter 1 
Introduction 
 
This thesis work focus on the development of a computational model for 
nanoparticle transport and deposition in pulmonary vasculature. In this chapter, 
pulmonary drug delivery, the application of nanoparticle on medicine, various 
nanoparticles properties, motivations to do the study and proposed work are addressed. 
 
1.1 Pulmonary Drug Delivery 
Due to the advantages that the lung has a large absorptive surface area but 
extremely thin absorptive membrane and good blood supply, pulmonary drug delivery 
has gained growing attention as a non-invasive administration for systemic delivery of 
drug. Aerosol inhalation technique is commonly utilized in drug administration. Jet or 
ultrasonic nebulizers, meterd-dose inhaler (MDI) and dry-power-inhaler (DPI) are three 
commonly used clinical aerosols. Aerosol is deposited in the airways by diffusion, 
gravitational sedimentation and inertial impaction. The bioavailability and delivery 
efficiency can be modified by many factors, like aerosol particle size, shape, and surface 
chemical properties. Now, many inhalers products are available in Europe and USA, 
like Airomir, Asmol, Qvar, Ventolin and etc [1]. To spread drug throughout the airspace 
of lungs more evenly, a novel concept to deliver drugs by using perfluorocarbon liquid 
is proposed recently. By this way, up to 100 times more active substance can be 
delivered to the diseased lungs. Despite the recognized advantages of pulmonary drug 
delivery system has been exploited, it still be limited mostly to treatment of lung-
associated diseases, like asthma, cystic fibrosis and respiratory infection for a long time. 
Until recent few decades, broader utilities of either localized or systemic delivery of 
drug from lung vasculature receive as much attention as it deserved [2]. Until 1990, the 
first descriptions of inhaled insulin for treatment of diabetes patients was recorded. The 
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advantages over injections were not only in term of patient compliance but also in terms 
of increased bioavailability. 
 
1.2 Application of Nanoparticle in medicine 
The biological and medical communities have developed various applications 
based on the unique properties of nanomaterials, like contrast agents for cell imaging 
and therapeutics for cancer treatment. These unique properties and potential 
applications offered by nanoparticles attract the attentions of scientists, engineers and 
medical researchers. For example, nanoparticles can imbibe drug into their core or coat 
drug into their surface to fight against cardiovascular disease and various cancers. Their 
half time in circulation and deposition distribution can be modulated by their size and 
shape which can be easily achieved by advanced micro-fabrication technology. The 
drug release process can even be controlled by other external properties like PH, 
temperature or magnetic field. Over the past decade, we have witnessed so many 
researches and developments of nanoparticulate system for diagnostic imaging and 
targeted therapeutic applications [3-9]. Various nanoplatforms, including liposomes 
[10,11], polymeric micelles [12-14], quantum dots [15,16], Au/Si/polymer shells [17-
19], and detrimers [20-22] have been established to develop smart drug carriers. These 
technologies have provided the possibility of delivering drugs to specific cells, which 
is also called targeted drug delivery. The goal of targeted drug delivery is to localize, 
prolong, target and have a controllable drug interaction with the diseased tissue. By this 
way, we can reduce the frequency of the dosages taken by patients, drug side-effects 
and the fluctuation in circulating drug levels. In April 2006, 130 nanotech-based drugs 
and delivery systems were being developed worldwide [23]. Nanomedicine sales 
reached $6.8 billion in 2004, with over 200 companies and 38 products worldwide. A 
minimum of $3.8 billion is being invested in nanotechnology R&D every year [24]. As 
the nanomedicine industry continues to grow, it will surly have a significant impact on 
the economy. 
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1.3 Engineered Nanoparticle Properties 
Properties such as size, shape, surface chemistry play an important role in 
nanoparticle transport and deposition. Size, as a key characteristic of nanoparticles has 
been extensively studied in literature. For example, it is well known that spherical 
particles bigger than 200nm can be easily filtered by the liver. On the other side, 
particles smaller than 10nm can be quickly cleared by the kidney or through 
extravasation. Thus, particles with diameters of 10-200nm are the ideal drug carriers in 
vascular circulation system [25]. Similar to size, shape is also a fundamental property 
of nanoparticles. For example, it is reported that non-spherical shape particles have 
remarkably higher adhesion probability, comparing to spherical for a given particle 
volume [26]. Fig. 1.1& 1.2 shows some products of nanoparticles with different sizes 
and shapes. What’s more, according to the study of Geng et al. [27], non-spherical 
particle has higher chances of survival during the circulation in vascular system 
compare to its counterpart spherical ones. Besides size and shape, surface 
functionalization of nanoparticle also determines the adhesion capability of 
nanoparticles. For nanorods, it is reported that compared to uniform coating, Janus 
coating at the two ends of nanorods leads to better adhesion [28,29]. By the 
immobilization of polyethylene glycol (PEG), protein adsorption and phagocytosis of 
particles in vivo would decrease [30].  
 
 
Figure 1.1 BioPure Silver and Gold NPs from 
http://nanocomposix.com/kb/nanotoxicology/particle-selection 
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Figure 1.2 A: BioPure silver nanospheres; B: nanoComposix silver; C: nanoComposix 
silver nanowires nanoplates from 
http://nanocomposix.com/kb/nanotoxicology/particle-selection 
 
1.4 Motivations to Model Nanoparticle Transportation and Deposition 
Although nanoparticles offer more advantages than other conventional drug carriers, 
their transport and deposition in human vasculature have not been fully understood. 
One reason is that nanoparticles are too small to be visualized and tracked by 
experiments in vivo. Another is that the biological environment in vivo is very complex 
for nanoparticles. To achieve better delivery efficacy, many factors, including the 
diseased area type, size, location and the patient’s physical parameters (e.g. vascular 
diameter, blood flow rate and etc.), should be considered. It is very challenging to study 
only one or two factors’ influence and keep other parameters same by experiment in 
vivo. However, validated computational fluid-particle dynamics (CFPD) simulations 
provides us a non-invasive, accurate and cost-effective means to obtain such 
information. 
Size, as a key characteristic of nanoparticles, directly influences the mechanism of 
deposition. For large particle, like micron particles, the main deposition mechanism is 
inertia effect. For smaller particle, like sub-micron particles, Brownian motion becomes 
stronger and dominantly affects the result. Besides that, other factors, including particle 
shape, fluid viscosity, fluid velocity, heart rate and vascular geometry, should be 
considered as well. Many researches have been conducted on how particle size, shape 
and velocity influence its transport and delivery. For example, J. Tan et al. [31], B. 
Asgharian et al. [32], Toby Lai [33] and Barbara M. Johnston et al. [34]. Either simple 
A B C 
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bifurcate branch or symmetric simulated ideal model is used in their studies to 
characterize the effects of nanoparticles properties. For example, it was reported that 
nanoparticles with smaller size bind fast than bigger ones, because diffusion coefficient 
is inversely proportional to the particle size in Y. Liu [26]. In that paper, only 10nm and 
100nm particles have been studied in capillary vessel with diameter of 10μm and 20μm. 
The author did not give out a method to link the micro-scale particulate model with 
multi-scale model of organ level. The latter is more beneficial to nanoparticle 
distribution prediction and drug dosage administration. 
It is not trivial to reconstruct a large scale vasculature network and input into 
computational model. The geometry of the model does have significant influence on 
the fluid velocity field, thus on the particle transportation and deposition. Some 
phenomena are even contradictory in realistic model and artificial model, reported by 
Natalya Nowak et al. [35]. In the paper, they simulate the micro-particles delivery and 
deposition in human lung airway and compare the result between artificial model and 
realistic human trachea model. The result shows more particles stick at straight vessel 
in realistic trachea model, which is opposite to that in an artificial model. In an artificial 
model, because of the relatively smoother and more symmetric geometry, almost no 
particle sticks at straight vessel wall. The influence of complex geometry is also 
reported by B. Asgharian [32]. When particle size is small, the loss mechanisms are due 
to sedimentation and diffusion combined. More particles deposit in lower airways, and 
this pattern is the same in all geometries. But, when particle size is large, the main loss 
mechanism is impaction, which is strongly dependent on geometry. More particles 
deposit in upper airways in the stochastic model, which is different in other two 
symmetric models where particles still deposit more in lower parts. So a realistic 3-D 
vascular model is necessary, if we want to do a more realistic simulation for drug 
delivery. 
Many angiographic image processing methods are reported in literatures, and two 
of them can be distinguished [36]. One is a global approach, aimed at automatically 
recognizing vessel skeletons on angiograms and at reconstructing an entire stationary 
or moving vascular tree. No detailed information on the local shape of vessels is needed. 
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Another one is a local approach, aimed at accessing the accurate 3-D geometry of a 
complex stenosed single or bifurcation vascular segment observed by radiologists, in 
order to extract quantitative parameters and qualitative information on vessel 
morphology. However, due to the limitation of CT or MRI scan technology, numerical 
reconstruction work is challenging. Although current image technology can get a 
vascular image up to 9 or 10 generation, reconstruction work for that is very difficult. 
The geometry beyond generation 5 is not likely to be accurate, according to Natalya 
Nowak [35], due to the limitation of MRI or CT resolution and the movement of patient 
during the scan procedure. Pathological irregular single or double cross-sectional shape 
may occur in the area of sudden lesion disruption or lumen occlusion. Also, because of 
the low MRI resolution, the image reconstructed by medical modeling software is 
always coarse and disconnected in small vessel part. To solve these problems, some 
methods have been proposed [36, 37]. Deformable model is commonly used. The 
algorithm consists of two steps: first, an initial model is built, based on the elliptic 
approximation that is valid for healthy single vessels and concentric stenosis, and then 
a deformation of the ellipse controlled by an optimization algorithm is applied in order 
to fit any pathological or branching cross-section [36].  
Computational fluid dynamic (CFD) simulation provides an attractive way to study 
the particle delivery on complex geometry model. Some examples are presented in Z. 
Zhang et al. [38], Ming-Jyh Chern et al. [39], and Jeffry D. Schroeter et al. [40]. High 
computational cost for the numerical simulation of large scale model is another problem. 
Thus, in most of current studies, either symmetric artificial geometry or small subunit 
of complex realistic geometry is used. 
 
1.5 Proposed Work 
In this paper, two artificial model and a realistic subunit of pulmonary vascular 
model reconstructed from the left lung MRI image are considered. Blood flow is treated 
as Newtonian and laminar fluid flow. Particle is tracked as discrete phase particle by 
integrating the force balance on the particle. A fully developed physiological velocity 
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profile is defined as the vascular inlet boundary condition. To overcome the 
incompleteness of vascular system, a proper pressure condition for the outlets is 
developed where a lumped mathematical model is derived to calculate the overall 
resistance at each outlet. A shear rate and particle size dependent ligand-receptor model 
[41] is used to define the particles binding probability. 
The objective of this paper are twofold: (1) reconstruct a realistic 3D pulmonary 
vascular model from MRI image, apply appropriate and boundary conditions, and 
develop a multi-scale approach for nanoparticle delivery in the 3D model; (2) 
characterize the effects of particle size, vascular geometry , and blood velocity on the 
drug particle transportation and deposition. In the following part of this paper, we will 
first introduce a pulmonary vascular geometry reconstruction method, then develop an 
approach to do CFD simulations for particle transport and deposition, and finally 
characterize the effects of some key factors which affect drug delivery efficiency based 
on the simulation result. 
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Chapter 2 
Numerical Modeling 
 
In this chapter, reconstruction of pulmonary geometry, governing equation for 
blood flow, particles transport theories and the proper boundary condition will be 
introduced. 
 
2.1 Reconstruction of pulmonary geometry 
To study the influence of vascular geometry on particles deposition, four different 
lung models are built in this research. The first one is an artificial artery model, the 
second one is an artificial vein model, the third one is a realistic lung model with the 
original rough surface obtained from MRI image, and the last one is the same realistic 
lung model with an over-smoothed surface. Different softwares such as Vascular 
Modeling Toolkit (VMTK), Geomagic Studio and Inventor are used to reconstruct 
model structures. Moreover, ICEM-CFD is utilized for mesh generation. 
 
2.1.1 Artificial Geometry 
To construct the three-dimensional artificial lung model, two assumptions are made: 
(1) the branching angel at each bifurcation is 60 degree, and (2) the angel of rotation of 
the plane of the bifurcation originating in each daughter branch is 90 degree [35]. Here, 
a four generations subunit artery model and a five generations subunit vein model are 
built in Invertor as shown in Fig. 2.1A & B. The length and diameter of each generation 
is shown in Table 2.1. However, because of the different diameters of parent and 
daughter vessels, it would lead to discontinuities at the bifurcations. So another 
assumption is made here: different generation branch are connected by a frustum. The 
large diameter of the frustum is set to be equal to the diameter of the parent branch and 
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the small diameter of the frustum equal to the diameter of the daughter branch. The 
length of the frustum is set to make the upper surfaces (circles) of the two daughter 
branches tangential, as shown in Fig. 2.2 
 
   
Figure 2.1 Artificial Model, A: artery model; B: vein model 
 
 
Figure 2.2 3-D view of section close to the bifurcation area of artificial vascular 
geometry. 
 
 
Artificial 
artery model 
Generation # Length (mm) Diameter (mm) 
1 7.60 5.60 
2 12.70 4.50 
3 10.70 3.50 
4 9.00 2.80 
A B 
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Artificial 
vein model 
1 0.48 0.15 
2 0.31 0.096 
3 0.26 0.056 
4 0.19 0.036 
5 0.20 0.02 
Table 2.1 Length and diameter of each branch 
 
2.1.2 Realistic Geometry 
In this study, an open source software called VMTK was used to reconstruct the 
realistic pulmonary geometry. A Magnetic Resonance Imaging (MRI) based Digital 
Imaging and Communications in Medicine (DICOM) image of a human lung 
vasculature was imported to VMTK and converted to Visualization Toolkit (VTK) 
format first. Then a deformable surface was extracted according to the image data and 
the chosen deformation parameters, as shown in Fig. 2.3. It is a whole lung vascular 
model, which includes up to 9 generations. It should be noted that because of the large 
range of branches diameter and grey scale threshold, it is almost impossible to construct 
the whole vessel in one process. Thus, individual branches are built part by part and 
merged together later. 
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Figure 2.3 Lung vasculature geometry reconstructed from a MRI image, courtesy of 
Ender A. Finol, Department of Biomedical Engineering, University of Texas San 
Antonio 
 
Since the model is deformable, it is likely that some outlets are closed with a blobby 
appearance. Therefore, it is important to clip the blobby endcaps manually. Although, 
a fully developed parabolic inlet boundary condition has been applied at inlet, to make 
sure the flow entering and leaving the computational domain is fully developed, flow 
extensions are added. All the flow extensions are cylinder whose ratio of height to 
diameter is 2.  
It is extremely challenging to model particle delivery in such a complex vascular 
system that has vessels with diameter from millimeters to centimeters. To develop 
proper boundary conditions for that is also nontrivial because it has over 200 outlets 
and is highly asymmetrical. As a first step toward modeling particle delivery in lung 
vasculature, we select a typical portion of the lung vasculature consisting of 4 
generations, as shown in Fig. 2.4A. To illustrate the effects of vascular wall smoothness 
and characteristic, another model was built as shown in Fig. 2.4B. In this model, coarse 
surface has been over-smoothed with Geomagic Studio. 
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Figure 2.4 Four-generation subunit of pulmonary vascular geometry. (a) is the original 
subunit; (b) is the over-smoothed subunit 
 
2.2 Mesh 
In this study, the mesh model was generated with ICEM-CFD. In order to acquire 
a better numerical estimation of flow field near vessel’s wall and accordingly, carefully 
track particles, a very small mesh size has been employed near boundaries. To reduce 
the computation cost of universal small mesh size, a non-uniform mesh is also applied 
as shown in Fig. 2.5. In this mesh model, size of elements at the center is larger than 
that of elements near the boundary. Delaunay mesh method [42] was adopted and two 
prism layers were created near the boundary. The prism layer’s initial height is 0.02mm, 
following exponential growth law with the height ratio of 1.2. The final mesh features 
about 9.263 million elements. Typical run times for the fluid flow and particles delivery 
simulation on a 20 processors workstation with parallel algorithm was approximately 
10-20 h. 
 
B A 
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Figure 2.5 A typical mesh over a cross-section of a lung vessel. Mesh size is large in middle 
and small near boundary. 
 
 
 
Figure 2.6 Mesh study of particle deposition in the original geometry with pulsatile 
inlet flow. 
 
To validate the mesh model, models with different mesh sizes (The minimum mesh 
size limits are 0.2, 0.15, 0.125 and 0.1mm respectively) have been run in a same flow 
and boundary conditions. The results is shown in Fig. 2.6. The result would not change 
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when we continue reducing the grid size. To study the different deposition fractions of 
different vascular parts, the vascular network is divided to different regions, as shown 
in Fig. 2.7. Each color represents different regions of the lung vasculature, as labeled 
in Fig. 2.7. 
 
2.3 Governing Equations for Blood Flow 
In general, blood flow in tapered elastic vessels is pulsatile flow. The fluid is non-
Newtonian. Computational fluid dynamics, which requires solving the Navier-Stokes 
equation, together with appropriate non-Newtonian constitutive relations for blood 
should be used. It also needs to be coupled with the dynamics of the compliant vessels 
through which blood flows. But for large arteries, blood can usually be modeled as 
incompressible and Newtonian [43].  
In this study, blood flow is assumed to be laminar and Newtonian. A commercial 
finite-volume- based CFD solve, Fluent 14.5.0 (ANSYS Inc.) was used for flow 
Yellow:              gen-1  
Blue:                bif-1 
Orange:              gen-2 
Light sky blue:         bif-2 
Pink:                gen-3  
Green:               bif-3 
Purple:              gen-4 
 
Figure 2.7 Mesh model of lung vasculature split to different regions.(Gen: 
Generation; Bif: Bifurcation) 
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simulation. The blood flow is governed by the Momentum Conservation Equation and 
Mass Conservation Equation. 
𝜕
𝜕𝑡
(𝜌?⃗?) + ∇ ∙ (ρ?⃗??⃗?) = −∇p + ∇ ∙ (𝜏) + ρ?⃗? + ?⃗?               (1) 
Where p is the static pressure, 𝜏 is the stress tensor (described below), ?⃗? and ?⃗? 
are the gravitational body force and external force, respectively.  
The stress tensor 𝜏 is given by  
𝜏 = 𝜇[(∇?⃗? + ∇?⃗?𝑇) −
2
3
∇ ∙ ?⃗?𝐼]                     (2) 
Where μ is the molecular viscosity, 𝐼  is the unit tensor, and the second term on 
the right hand side is the effect of volume dilation. 
𝜕𝜌
𝜕𝑡
+ ∇ ∙ (𝜌?⃗?) = 0                         (3) 
Eqn. 3 is the general form of the mass conservation equation, or continuity equation 
and is valid for incompressible as well as compressible flows. 
All the blood properties used in this study are summarized in table 2.2 
 
Properties value 
Density 1060kg/m3 
Viscosity 0.003Pa•s 
Thermal Conductivity 0.52W/m °C 
Table 2.2 Blood properties 
 
2.4 Governing Equations for Particles Transportation 
 2.4.1 Particles Tracking 
Nanoparticles are delivered to human body by various methods, including 
inhalation, oral delivery and injection. Among these methods, intravenous injection (IV) 
is commonly used. After IV, nanoparticles would transport along the blood flow 
through the vascular network. In common, nanoparticles can be affected by physical 
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interactions with blood components, in particular with red blood cell. For simplicity of 
this work, it is assumed that particles transport and distribution are only affected by the 
blood flow and the interactions with vascular wall. 
Trajectory of a discrete phase particle is predicted by integrating the force balance 
on the particle, which is written in a Lagrangian reference frame. This force balance 
equates the particle inertia with the forces acting on the particle, and can be expressed 
as 
𝑑𝑢𝑝
𝑑𝑡
= 𝐹𝐷(?⃗⃗? − ?⃗⃗?𝑝) +
?⃗?(𝜌𝑝−𝜌)
𝜌𝑝
+ ?⃗?                      (4) 
Where ?⃗⃗? is the fluid phase velocity, ?⃗⃗?𝑝 is the particle velocity, 𝜌 is the fluid 
density, 𝜌𝑝  is the density of the particle,  ?⃗?  is an additional acceleration term, 
𝐹𝐷(?⃗⃗? − ?⃗⃗?𝑝) is the drag force per unit particle mass and  
𝐹𝐷 =
18𝜇
𝜌𝑝𝑑𝑝
2𝐶𝑐
                               (5) 
Here, 𝑑𝑝 is the particle diameter, μ is the molecular viscosity of the fluid, 𝐶𝑐 is 
the Cunningham correction factor, which will be mentioned later. 
In this study, it is assumed that the density of particle (𝜌𝑝) is the same as density of 
blood (𝜌). Particles are injected with the same time step as the calculation time step of 
flow from the inlet. In total, 2 million particles are released continuously from inlet for 
one second. Particles size ranges from 1nm to 500nm with uniform distribution. The 
particle initial position is also random allocated at the inlet. Trapezoidal and implicit 
tracking schemes are chosen for higher order and lower order numerical tracking 
schemes respectively. Tolerance of relative error is set to 10-5, and the maximum 
number of integration steps is 106. 
 
2.4.2 Nanoparticle Brownian Dynamics 
Brownian motion describes the random motion of submicron particles which is 
subjected to the random collisions from the surrounding liquid molecules [44]. To 
include such effects in this simulation, the Brownian force 𝐹𝑏𝑖  is modeled as a 
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Gaussian white noise process with spectral intensity 𝑆𝑛,𝑖𝑗 given by 
𝑆𝑛,𝑖𝑗 = 𝑆0𝛿𝑖𝑗                          (6) 
Where 𝛿𝑖𝑗 is the Kronecker delta function, and  
𝑆0 =
216𝜐𝑘𝐵𝑇
𝜋2𝜌𝑑𝑝
5(
𝜌𝑝
𝜌
)2𝐶𝑐
                         (7) 
T is the absolute temperature of the fluid, 𝜐 is the kinematic viscosity, Cc  is the 
Cunningham correction, and kB is the Boltzmann constant [45]. 
Cunningham factor is used to correct Stokes’ drag law, and can be expressed as 
Cc = 1 +
2𝜆
𝑑𝑝
(1.257 + 0.4𝑒−(1.1𝑑𝑝/2𝜆)                 (8) 
Where 𝜆 is the molecular mean free path. Here, the mean free path 𝜆 for blood 
is assumed as 0, due to the high molecular density. Thus, the Cunningham factor is 1 
[46]. 
Amplitudes of the Brownian force components are defined by 
𝐹𝑏𝑖 = 𝜁𝑖√
𝜋𝑆0
∆𝑡
                            (9) 
Where 𝜁𝑖 is zero-mean, unit-variance-independent Gaussian random number, and 
∆𝑡 is the calculation time step. The amplitudes of the Brownian force components are 
evaluated at each time step of simulation. 
 
2.4.3 Saffman Lift Force 
Small particles in shear field should experience a lift force perpendicular to the 
direction of flow. The lift force originates from the inertia effects in the viscous flow 
around the particle and move particles from higher pressure region to lower pressure 
region. For sub-micron particles, the Saffman’s lift force usually cannot be neglected. 
The generalized expression of Saffman’s lift force is: 
?⃗? =
2𝐾𝑣
1
2⁄ 𝜌𝑑𝑖𝑗
𝜌𝑝𝑑𝑝(𝑑𝑙𝑘𝑑𝑘𝑙)
(?⃗? − ?⃗?𝑝)                    (10) 
Where 𝐾 =2.594 and 𝑑𝑖𝑗 is the deformation tensor.  
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2.5 Particles Binding Model 
In this study, a receptor-ligand model proposed by Decuzzi et al. [41] is adopted to 
calculate the particle deposition probability. The adhesive strength of particles depends 
on the selective binding of the molecules expressed over the target surface and their 
counter-molecules conjugated at the particle surface. The dislodge forces are influenced 
by the other physiological factors as wall shear stress, particle shape and size, as 
sketched in Fig. 2.8. 
 
 
Figure 2.8 Illustration of a spherical particle in specific contact with vascular wall. 
𝛿𝑒𝑞 is the separation distance between the spheroidal particle and the vascular wall; h0 
is the maximum distance of the spheroidal particle from the vascular wall at which a 
specific bond can occur; d is the diameter of the particle. 
 
Dislodging forces, the drag force F along the flow direction and the torque T , 
are affected by the particle size d, separation distance from the vascular wall l and the 
shear stress μS at the wall. Their explicit expressions are shown as: 
F = 6πlμS𝐹𝑆                              (11) 
and   
T = 0.5π𝑑3𝜇𝑆𝑇𝑆                             (12) 
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 Where the coefficients, 𝐹𝑆 and 𝑇𝑆 depend on aspect ratio. Here, 𝐹𝑆=1.668 and 
𝑇𝑆=0.944 for sphere particles [47]. 
When the particle surface and the vascular wall are close enough, the ligands with 
surface density ml on the particle and the receptors with surface density 𝑚𝑟 on the 
vascular wall can form bonds stochastically. A probability of adhesion 𝑃𝑎 is introduced 
here, which defined as the probability of having at least one bond formed between the 
particle and the substrate surface. 
𝑃𝑎 = 𝑚𝑟𝑚𝑙𝐾𝑎
0𝐴𝑐exp [−
𝜆𝑓
𝑘𝐵𝑇
]                       (13) 
where 𝐾𝑎
0 is the association constant at zero load of the ligand-receptor pair; 𝐴𝑐 
is the interaction area between the particle and the substrate; f is the force per unit of 
ligand-receptor; 𝜆 is a characteristic length of the ligand-receptor bond; and 𝑘𝐵𝑇 is 
the Boltzman thermal energy. 
From Fig. 2.8, 𝐴𝑐 can be easily derived as: 
𝐴𝑐 = 0.25π𝑑
2(1 − (1 −
2∗(ℎ0−𝛿𝑒𝑞)
𝑑
)2)                       (14) 
f can be expressed as the ratio of total dislodging force 𝐹𝑑𝑖𝑠  and the area of 
interaction Ac multiplied by the surface density of the receptors, that is f =
𝐹𝑑𝑖𝑠/(𝑚𝑟𝐴𝑐). As usually done, it is assumed that the force 𝐹𝑑𝑖𝑠 is uniformly shared 
among the bonds; whereas the torque 𝑇  is only shared uniformly within the bonds 
which are stretched, thus, for sphere particle, 
𝐹𝑑𝑖𝑠
𝐴𝑐
=
𝐹
𝐴𝑐
+
2𝑇
𝐴𝑐𝑟0
=
3𝜋𝑑(𝑑/2+𝛿𝑒𝑞)𝜇𝑆𝐹
𝑆
𝐴𝑐
+ 𝜋𝑑3𝜇𝑆𝑇𝑆/𝐴𝑐𝑟0           (15) 
Where r0 is the radius of the interaction surface. 
Combining Eqns. (13), (14) and (15), Pa can be expressed as 
𝑃𝑎 = 𝑚𝑟𝑚𝑙𝐾𝑎
0πr0
2exp [−
𝜆𝑑𝜇𝑆
2𝑘𝐵𝑇r0
2𝑚𝑟
[6(𝑑/2 + 𝛿𝑒𝑞)𝐹
𝑆 + 2
𝑑2
𝑟0
𝑇𝑆]]        (16) 
In this thesis, the values of parameters are chosen and summarized in table 2.3. 
 Parameters value 
𝑚𝑟  10
14m2 
𝜆 10-10m 
𝑘𝐵 1.38×10
-23m2kg/s2K 
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𝑚𝑟 300K 
ℎ0 10
-8 
𝛿𝑒𝑞  5×10
-9 
Table 2.3 Binding probability parameters 
 
To simplify having realistic and proper values of 𝐾𝑎
0 and 𝑚𝑙 for particles with 
different sizes, we made an assumption that at zero shear stress, the binding probability 
is assumed to be one. The proper values of 𝐾𝑎
0 and 𝑚𝑙 depends on particle type of 
ligand-receptor used and local chemical conditions, and usually requires complex 
experimental tests on particle binding dynamics. To simply this process and make our 
results applicable to delivery of general types of particles, we normalized the particle 
binding probability under a range of shear stress to that under zero shear stress.  In 
another word, the binding probability is assumed to be one at zero shear stress, which 
is reasonable according to experimental observations. The particle binding probability 
for different particle size exposed to various dislodging shear stress is shown in Fig. 
2.9. 
 
Figure 2.9 Binding probabilities for particles of different size (10nm, 100nm, 500nm, 
1μm and 3μm) under a range of shear stresses. 
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2.6 Boundary Condition 
2.6.1 Inlet Velocity Profile 
The blood flow in pulmonary arteries is pulsatile. As shown in (Fig 2 of reference 
[48]), the flow patterns in the pulmonary vasculature of normal subjects showed no 
retrograde flow during diastole. Furthermore, there was no apparent difference between 
the flow profiles of right and left pulmonary arteries in these subjects which can be 
interpreted into more or less equal perfusion for both vascular beds. As mentioned 
before, just a small portion of realistic human left pulmonary vasculature has been used 
for modeling particle transport and deposition. Thus, the appropriate inlet velocity into 
this model structure has to be carefully calculated. For this purpose, experimentally 
measured cardiac flow to left pulmonary artery along with morphometric data of human 
pulmonary vasculature is used in this study [48]. The approximate number and diameter 
of vessels in every generation can be extracted from this data set. Using inlet surface 
area, the appropriate number of vessels in that specific generation can be interpolated. 
Subsequently, the inlet flow rate into our reference geometry can be calculated. In order 
to employ experimentally measured left pulmonary artery data points in our simulation, 
least square method is utilized to determine coefficients of Fourier series expansion. 
Moreover, fully developed flow assumption is used for the inlet velocity profile in order 
to eradicate unrealistic effect of developing region on simulation results. Thus, inlet 
profile will have a parabolic outline which is changing with time during cardiac cycle 
as shown in Fig. 2.10. 
 
23 
 
 
Figure 2.10 Instantaneous inlet velocity of pulmonary artery. 
 
2.6.2 Outlet Boundary Condition 
Using Strahler’s ordering system [49], Kassab et al. [50] defined every vessel 
between two successive bifurcation points as a segment. Moreover, they identified 
vascular element as a set of segments of the same order connected in series from the 
inlet to the outlet of the arterial tree. The segment length is the distance between 
bifurcation points. The diameter of an element was computed as the average of the 
diameters of the segments that make up the element. Similarly, the length of an element 
was obtained by adding the lengths of the segments within that specific element. 
Moreover, Huang et al. [51], in their morphometric study of human pulmonary arteries, 
introduced a matrix that characterizes the connectivity of lung arteries. In this matrix, 
C(m,n) is the ratio of the number of order m elements, evolving directly from order n 
elements, to the total number of order n elements. This connectivity matrix and 
statistical data set were derived for a human left pulmonary vasculature. Furthermore, 
flow circuits can be built of elements because segments are already connected in series. 
Thus, we can develop a code to generate a tree of pulmonary elements using 
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connectivity information of pulmonary elements for deriving the overall resistance at 
each outlet of our image-based model structure. The smallest vessels in this data set 
have a diameter of 20 µm, slightly larger than capillaries. It should also be mentioned 
that the outlets of this morphometry-based tree, the order 1 elements, were modeled as 
emptying into a reservoir with relative zero pressure. Furthermore, the dynamic 
viscosity was set to 0.04 poise except in vessels of order 1, 2, and 3, where the values 
were assumed to be 0.025, 0.03, and 0.035 poise, respectively, to account for the 
reduced apparent viscosity in lumens with small diameters [52]. Finally, the overall 
resistances at the beginning of every generation have been calculated as shown in Fig. 
2.11. Thus, during CFD solving procedure, the outlet pressure will be updated at every 
iteration using volumetric outflow and downstream calculated resistance. Here, in our 
model, generation order of downstream vessel may vary from 8 to 12, see Fig. 2.11.   
 
 
 
Figure 2.11 The overall resistances at the beginning of every generation of vascular 
network. Out model ranges from 8th to 12th.generation 
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Chapter 3 
Result and Discussion 
 
In the following section, the results of particle tracking simulation in lung 
vasculature are presented and discussed in detail. It should be mentioned that the 
entrance effect on modeling results was minimized by adding flow extensions and fully 
developed inlet flow profile, and unless otherwise stated, all the results of artificial 
geometry are referred to artificial artery model. Small size artificial vein model is only 
used to do a comparison and verify the CFD method. Furthermore, since available 
surface areas for particle binding in artificial and realistic model structures are different, 
some results have been normalized with the corresponding surface area.  
 
3.1 Steady State flow 
Steady inlet velocities within physiological range of 0.05 to 0.2 m/s have been 
chosen to compare particle deposition with respect to particle diameter size. For this 
purpose, 2 million particles of different sizes in uniform distribution have been injected 
into original geometry model with steady state flow condition. The results are listed in 
Fig. 3.1A and Fig. 3.1B in two different ranges of particle diameters. As depicted in Fig. 
3.1A, particles have higher deposition fraction under inlet velocity of 0.15 m/s than that 
under other inlet velocity in majority of diameters. Furthermore, since diffusion 
mechanism is the dominant driving force of small size particles in low flow rate region, 
particles with diameters less than 20 nm have the highest deposition percentages in 0.05 
m/s inlet velocity case, see Fig. 3.1A. As mentioned before, the particle binding 
probability would decrease by increasing shear stress and particle size, as illustrated in 
Fig. 2.9. It is depicted in Fig. 3.1B that the binding fraction will gradually decrease as 
particle diameter increases. Furthermore, this decrease is also intensified by increasing 
luminal flow rate due to decreased particle binding probability with increased shear 
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stress. This phenomenon is consistent with the particle Brownian motion speed in blood, 
as shown in Fig. 3.2. Particles with diameters less than 20nm have relatively higher 
Brownian motion speed. Particle displacement decreases dramatically with the 
increased particle size at the beginning, and then decrease slowly after 20nm. 
 
 
 
 
Figure 3.1 Comparing particle deposition fraction at two different ranges of particle 
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sizes under various steady flow rates: A. 1 to 100nm, B. 1nm to 3µm 
 
 
Figure 3.2 Displacement of particles with different sizes due to Brownian motion in 
different time periods. 
 
To investigate the effect of fluid flow field on particle binding pattern, particle 
deposition fraction has been studied in original, over-smoothed and artificial Weibel 
geometry under a steady state flow velocity of 0.1 m/s. It should be noted that the main 
difference between the original and the over-smoothed model structures is the 
smoothness of vessel’s surface. As shown in Fig. 3.3, the percentage of bound particles 
is lowest for artificial geometry and highest for original geometry. Due to numerous 
surface imperfections in realistic model of lung vasculature, streamlines which start at 
the central regions of inlet surface (accordingly particles carried by them) have higher 
chance to get closer to the vessel’s wall and deposit. In other words, streamlines are 
more disturbed and fluid mixing is better in realistic vasculature. Thus, the deposition 
fraction is also influenced by surface smoothness. Hence our realistic geometry is 
significantly more favorable for particle binding compared to an ideal artificial 
geometry. 
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Figure 3.3 Particle deposition fraction using original, over-smoothed and artificial 
geometry with the same inlet flow rate. 
 
3.2 Pulsatile Flow  
Ten million particles with diameters ranging from 1 nm to 3 micron are released 
into the original geometry under a pulsatile inlet flow profile described in Fig. 2.10. 
The result for the deposition fraction of particles in various diameters is depicted in the 
Fig. 3.4A and Fig. 3.4B in two distinct extents of particle size. Moreover, binding 
distribution pattern of particles in steady flow condition is also added to these figures 
for comparison purposes. It should be noted again that the average inlet velocity during 
cardiac cycle is approximately 0.1 m/s, which is chosen for the steady case. As shown 
in Fig. 3.4A, for smaller particles, binding percentage is noticeably higher when 
particles are released in pulsatile flow stream because the fluid mixing can be 
considerably enhanced by unsteady flow. However, as diameter increases, particles 
deposition fraction decreases significantly because bigger particles would experience 
more detachment force during peak velocity time period and accordingly, can be easily 
dislodged from vessel’s wall. Consequently, they will have lower chance of successfully 
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depositing on vessel’s wall. 
 
 
 
 
Figure 3.4 Particle deposition fraction for particles of different sizes under steady and 
pulsatile blood flow. For better presentation, is demonstrated at two different particle 
diameter ranges A. 1 to 100nm, B. 1nm to 3µm 
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condition is applied. It can be observed from Fig. 3.5 that original geometry has the 
higher deposition rate than over-smoothed and artificial geometries. Furthermore, 
deposition fraction of particles with diameter less than 20nm is higher for over-
smoothed geometry in comparison with artificial geometry results. But for bigger 
particles, artificial geometry has slightly higher binding rate. Comparing Fig 3.3 to Fig 
3.5, it can be found that the particle deposition fraction in artificial geometry increase 
a lot under pulsatile flow condition. The particle deposition fractions in the other two 
geometries do increase some, but not as much as that in artificial geometry, which 
shows the influence of pulsatile flow on regular artificial geometry is stronger than that 
on complex realistic geometry. It is easy to understand because the complex structure 
of realistic geometry has already make the fluid flow better mixed than that in regular 
geometry under steady inlet flow condition. Thus, the enhancement of pulsatile flow on 
particle deposition fraction to realistic geometry is less than that to regular geometry. 
 
 
Figure 3.5 Effect of vessel surface smoothness on particle deposition fraction under 
pulsatile flow condition 
 
Cumulative profiles of particle deposition with respect to time are demonstrated 
for different simulations in which two million particles with diameters ranging from 1 
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nm to 0.5 µm are released in original geometry. It is also worthy to mention that 
particles are injected into pulsatile flow from 0.2s, peak of cardiac inlet velocity, in 
order to make sure the numerical solution for fluid field is converged and stable and 
also to eradicate early stage reverse flow effect on results. All profiles are normalized 
with respect to the total number of deposited particles in that specific simulation. Thus, 
their ultimate value would be one. Comparing results of steady cases, the deposition 
process finished faster in higher inlet velocities. The reason is that particles would move 
and leave lung vasculature faster in higher velocities. Thus, there won’t be more 
particles depositing on vessel’s wall after a certain period of time, see Fig. 3.6A.  
The blood traveling time through vasculature is approximately same for the case 
of pulsatile flow and 0.1 m/s steady velocity for both geometries (original and artificial). 
But as depicted in Fig. 3.6A, particles bind much faster in pulsatile flow even though 
they have 0.2s lag in their injection time. Moreover, it is observed that particles 
deposited more rapidly in artificial geometry. 
 Furthermore, instantaneous binding pattern of trapped particles is analyzed. The 
instantaneous number of particles deposited in each time interval for realistic cardiac 
flow in different geometries is derived and shown in Fig. 3.6B. By over smoothing 
luminal surface imperfections, we won’t be able to observe periodic particle binding 
pattern over time anymore. This feature is amplified for artificial model structure in 
which a peak of instantaneous deposition happens at the second pulsatile cycle. 
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Figure 3.6 Illustrations of deposition profile vs. time for various simulation 
parameters. A. Cumulative profiles of particle binding in different geometries and 
flow conditions. B. Instantaneous deposition profile of cardiac flow in geometries 
with different surface smoothness. C. Instantaneous profile of continuous particle 
injection in original geometry. 
 
Furthermore, a simulation with continuous injection of particles (1 million per 
second) into the original geometry was also undertaken to demonstrate the time history 
of particle deposition better, as shown in Fig. 3.6C. Previously, it was shown that 0.1m/s 
inlet condition has the highest deposition rate in steady state flow. But here in pulsatile 
pulmonary flow, it is observed that the peak of deposition rates mainly happens when 
the flow rate is maximal and accordingly almost no noticeable lag between these 
occurrences can be detected. Since this pattern is more discernible in the original 
geometry (Fig. 3.6B), higher particle velocity, better fluid mixing and the presence of 
stronger vortices in these luminal imperfections can attribute to this phenomenon. 
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3.3 Deposition Pattern 
To better understand the particle deposition pattern, the deposited location of 
particles are shown in three dimensions for original and artificial geometries in Fig. 3.7. 
It is observed that the particle deposition density is higher near bifurcation sections of 
the vasculature network in both original and artificial geometries. It can also be 
observed in artificial geometry that particles in luminal section of order 3 vessels have 
higher binding rate. All these phenomena can be explained by the blood flow field. As 
shown in Fig. 3.8, flow velocity is higher in the middle of the luminal section in steady 
case, but in unsteady case, higher velocity filed moves to the boundary because of the 
pulsatile flow field. Under the influence of Saffman lift force, particles are forced to 
move from high pressure (low tangential velocity) area to low pressure (high tangential 
velocity). Thus, more particles concentrate in those areas, which makes higher particle 
deposition fraction there.  
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Figure 3.7 3-D demonstration of deposition pattern when releasing 2 million particles 
with diameter ranging from 1nm to 0.5µm under pulsatile inlet flow in A. Original 
lung vascular geometry and B. Artificial Weibel geometry. 
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B 
Figure 3.8 Fluid velocity vector in unsteady case and steady case. A: fluid velocity 
vector of in unsteady case at the time of 0.45s. B: fluid velocity vector in steady case. 
 
In Fig. 3.9, the particle deposition density of the corresponding vasculature it is 
injected into is shown for steady and unsteady cases. It should also be noted that 2 
million particles with size ranging from 1nm to 0.5µm are injected into original 
geometry for both steady and pulsatile simulations. With much less streamline 
disturbance due to steady flow, particle deposition density in the first generation is the 
lowest for steady case. Particle deposition density is approximately uniform throughout 
all sections in steady flow, see Fig. 3.9A. 
In contrast, at the entrance of original geometry in unsteady case, since fluid mixing 
is enhanced when coupling with surface imperfections, a larger numbers of particles 
deposit in the first generation. Furthermore, deposited densities at bifurcation sites are 
considerably higher than that of luminal parts for pulsatile case as shown in Fig. 3.9B. 
Particle deposition density also increase by generation order, which indicates that 
particles can transport and deposit in later generations under unsteady flow compared 
to steady flow. And, to check whether the particle deposition pattern would shift in 
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much smaller vessels, another case with smaller size artificial vein geometry has been 
studied. This geometry has the same structure with previous artificial weibel geometry, 
but different size (branch diameters range from 0.02mm to 0.15mm). The result of this 
artificial vein model under steady state case is shown in Fig. 3.10. It can be found that 
the particle deposition density is dramatically increased and particles are more easily to 
deposit at beginning parts. But, for later parts, the deposition density of particles shows 
the similar pattern with that in large scale model.  
For studying whether particle sizes will influence topographical distribution 
pattern, the number of deposited particles have been normalized with respect to their 
target vasculature surface area as well as total number of deposited particles within that 
diameter range. Using this technique, it is observed that small size particles have higher 
binding rate at the entrance region, see Fig. 3.11. Moreover, in contrast to particle 
deposition in respiratory system in which there can be found a specific correlation 
between the size of particle and the generation order [32], no clear correlation is 
observed in lung vasculature. Furthermore, it should also be mentioned that particle 
binding distribution in over-smoothed geometry also have the same feature as original 
one, but with the lower mass density. But, for artificial vein model, as shown in Fig. 
3.12, it can be found that most of deposited particles are those in the range of 1-50nm, 
but for larger particles, the deposition number is almost zero. These results also proves 
that Saffman lift force moves particles to some areas of higher tangential velocity when 
flow rate is high, and because of the high viscosity and weak particle Brownian motion 
in blood, only when flow rate is very low (0.0176m/s in our artificial vein model), 
Brownian motion shows dominant influence on deposition process. 
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Figure 3.9 Deposition densities of different surface areas (Gen1, Bif1, Gen2, Bif2, 
Gen3, Bif3 and Gen4) of original geometry under A. steady 0.1 m/s flow; B. pulsatile 
flow condition. 
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Figure 3.10 Deposition densities of different surface areas of artificial vein model 
under steady 0.0176m/s flow. 
 
 
Figure 3.11 Normalized deposited number of particles with different diameter ranges 
depositing on various regions of original geometry. 
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Figure 3.12 Normalized deposited number of particles with different diameter ranges 
depositing on various regions of artificial vein geometry. 
 
Particle distribution pattern over time is shown in Fig. 3.13. At early stages of 
particle injection into blood stream, majority of particles are trapped at bifurcation sites 
first. As time goes, those particles close to vessel wall under low flow speed would also 
have the chance to diffuse to luminal sections.  
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T = 8s 
Figure 3.13 3-D representation for trapped location of injected particles in different 
times A. 1s B. 2s C. 8s after starting the simulation with cardiac inlet flow. 
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Chapter 4 
Conclusion and Future work 
 
4.1 Conclusion 
Numerical modeling of targeted drug delivery provides a quantitative description 
for drug transport and deposition in biological system. Thus, it can be used to evaluate 
efficiency of drug delivery in medicine treatment. To characterize the particle transport 
and deposition mechanism, a 4 generations realistic pulmonary vasculature was 
reconstructed and utilized in the numerical simulation. Proper boundary conditions for 
flow field and binding mechanism of particles have been defined. It should be noted 
that the method introduced in this thesis can also be used in larger vascular network 
reconstruction.  
The influence of particle size has been studied quantitatively. The simulation result 
shows that smaller particles have more chance of binding on vascular wall. The reason 
of that is the relatively strong Brownian motion and binding probability of smaller 
particles. But unlike the particle transportation in airflow, the diffusion effect of particle 
is not so strong. We cannot see the obvious relationship between particle size and 
distribution pattern in blood flow. The deposition fraction increase with the branch 
generation order for all sizes particles from generation 2. This is different from particle 
transportation in airflow, where smaller particles stay more easily at upper region, due 
to the strong diffusivity.  
Vascular geometry, as another key factor, has been studied too. One symmetric 
artificial geometry and one over-smoothed realistic geometry have been utilized to 
make comparison with the original geometry. The results show different deposition 
fractions of different geometries. Particles are more easily to bind at realistic surface. It 
should be attributed to the fluid flow in the geometry with irregular surface. Due to the 
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vortices in realistic vascular geometry, the residual time of particles is longer than that 
in symmetric regular artificial geometry. Also, due to this reason, fluid is mixed well. 
Thus particles injected in the center have more chance to get closed to the vascular wall. 
So, to better predict the drug delivery efficiency in medicine treatment, realistic 
vascular geometry is necessary. 
Blood flow pattern also has significant influence on the particle transport and 
deposition. In this study, both steady flow and pulsatile flow have been studied. In 
steady flow cases, particle deposition fraction decreases with the increase flow velocity. 
Particle distribution is nearly uniform on different locations. Whereas, in pulsatile flow 
cases, particles deposition concentrates at bifurcation areas, where flow velocity is also 
higher. It should be noticed that the flow pattern also strongly depend on the shape of 
geometry. No vortex has been found in artificial model, though the inlet flow velocity 
is also pulsatile.  
In summary, the diffusion effect of particle in blood is not as strong as that in 
airflow. The main loss mechanism is impaction. The particle transport and deposition 
depend significantly on the particle size, vascular geometry shape and flow pattern. 
Such knowledge may help to shorten the cycle for design of the smart drug carrier and 
time to realize the personalized treatment for different patients. 
 
4.2 Future Work 
Though the method above is suitable to reconstruct multi-scale vascular geometry, 
only a 4 generation subunit of whole lung model is chosen to be used in this study. The 
reason is that large model needs high computation cost. Prior experience shows that an 
absolute minimum of 10,000-15,000 elements would be required to simulate each 
tubular portion and an associated bifurcation successfully [35]. Thus, a successful 
simulation for entire lung would require an equivalent number of elements in each of 
the 107 branches of the lung, which means more than 200GB RAM is necessary. One 
alternative solution to predict the drug delivery efficiency in relatively complete lung 
vasculature for particular patient is to cut a sample path of vasculature which we are 
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interested at, and either combine them with proper boundary conditions or couple with 
1-D vascular model. 
In addition, to better simulate the motion of nano or micron size particles in blood 
vessel, blood components, like the red blood cell (RBC) should not be neglected. 
Without a proper consideration of RBCs, the deposition fraction of drug particles would 
be lower estimated. It has been reported that RBCs significantly influence the particles 
dispersion [26]. RBCs and their interaction with fluid flow will be modeled by 
Immersed Finite Element Method (IFEM) formulation. An advanced model including 
all these factors will be developed in future.  
After all these achieved, model predictions will be validated against experimental 
and clinic data. Thus, the ultimate goal of this study would be given patient vascular 
network, to design drug carriers and personalized treatment to maximize the drug 
delivery efficiency, and minimize the drug dosage and side effects for each individual 
patient. 
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